Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Alessandra Morano, Luigi Iannone, Caterina Palleria, Martina Fanella, Anna Teresa Giallonardo, Giovambattista De Sarro, Emilio Russo & Carlo Di Bonaventura. (2019) Pharmacology of new and developing intravenous therapies for the management of seizures and epilepsy. Expert Opinion on Pharmacotherapy 20:1, pages 25-39.
Read now
Read now
Simona Lattanzi, Francesco Brigo, Claudia Cagnetti, Alberto Verrotti, Gaetano Zaccara & Mauro Silvestrini. (2018) Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy. Core Evidence 13, pages 21-31.
Read now
Read now
Xinshi Wang, Xin Tian, Yong Yang, Xi Lu, Yun Li, Yuanlin Ma, Yanke Zhang, Fangshuo Zheng, Shanshan Lu, Demei Xu, Xin Xu, Wei Wang & Xuefeng Wang. (2017) POSH participates in epileptogenesis by increasing the surface expression of the NMDA receptor: a promising therapeutic target for epilepsy. Expert Opinion on Therapeutic Targets 21:12, pages 1083-1094.
Read now
Read now
Carlo Di Bonaventura, Angelo Labate, Marta Maschio, Stefano Meletti & Emilio Russo. (2017) AMPA receptors and perampanel behind selected epilepsies: current evidence and future perspectives. Expert Opinion on Pharmacotherapy 18:16, pages 1751-1764.
Read now
Read now
Edoardo Ferlazzo, Emilio Russo, Laura Mumoli, Chiara Sueri, Sara Gasparini, Caterina Palleria, Angelo Labate, Antonio Gambardella, Giovambattista De Sarro & Umberto Aguglia. (2015) Profile of brivaracetam and its potential in the treatment of epilepsy. Neuropsychiatric Disease and Treatment 11, pages 2967-2973.
Read now
Read now
Articles from other publishers (25)
Fabio Perversi, Cinzia Costa, Angelo Labate, Simona Lattanzi, Claudio Liguori, Marta Maschio, Stefano Meletti, Lino Nobili, Francesca Felicia Operto, Andrea Romigi, Emilio Russo & Carlo Di Bonaventura. (2023) The broad-spectrum activity of perampanel: state of the art and future perspective of AMPA antagonism beyond epilepsy. Frontiers in Neurology 14.
Crossref
Crossref
Wei Zhao, Cong Xie, Xu Zhang, Ju Liu, Jinzhi Liu & Zhangyong Xia. (2023) Advances in the mTOR signaling pathway and its inhibitor rapamycin in epilepsy. Brain and Behavior 13:6.
Crossref
Crossref
Yiwei Gong, Cenglin Xu, Shuang Wang, Yi Wang & Zhong Chen. (2022) Computerized application for epilepsy in China: Does the era of artificial intelligence comes?. Acta Neurologica Scandinavica 146:6, pages 732-742.
Crossref
Crossref
Zhengwei Su, Yinchao Li, Shuda Chen, Xianyue Liu, Ke Zhao, Ying Peng & Liemin Zhou. (2022) Identification of Ion Channel-Related Genes and miRNA-mRNA Networks in Mesial Temporal Lobe Epilepsy. Frontiers in Genetics 13.
Crossref
Crossref
Maxime Lévesque, Giuseppe Biagini, Marco de Curtis, Vadym Gnatkovsky, Julika Pitsch, Siyan Wang & Massimo Avoli. (2021) The pilocarpine model of mesial temporal lobe epilepsy: Over one decade later, with more rodent species and new investigative approaches. Neuroscience & Biobehavioral Reviews 130, pages 274-291.
Crossref
Crossref
Bernhard J. Steinhoff & Anke M. Staack. (2021) Wenn Epilepsiechirurgie die personalisierte Therapie der Wahl ist: Muss Pharmakoresistenz wirklich immer zwingend belegt werden?When epilepsy surgery becomes the personalized first-line therapy: is drug resistance really an inevitable prerequisite?. Zeitschrift für Epileptologie 34:2, pages 197-201.
Crossref
Crossref
Annacarmen Nilo, Giada Pauletto, Gian Luigi Gigli, Alberto Vogrig, Pierluigi Dolso & Mariarosaria Valente. (2021) Perampanel as add-on therapy in epilepsies with known etiology: A single center experience with long-term follow-up. Epilepsy & Behavior Reports 15, pages 100393.
Crossref
Crossref
Pegah Khosropanah, Eric Tatt-Wei Ho, Kheng-Seang Lim, Si-Lei Fong, Minh-An Thuy Le & Vairavan Narayanan. (2020) EEG Source Imaging (ESI) utility in clinical practice. Biomedical Engineering / Biomedizinische Technik 65:6, pages 673-682.
Crossref
Crossref
Angelo Pascarella, Luigi Francesco Iannone, Giancarlo Di Gennaro, Alfredo D'Aniello, Edoardo Ferlazzo, Nazareno Gagliostro, Francesco Ursini, Paolo Bonanni, Nicola Paciello, Andrea Romigi, Umberto Aguglia, Giovambattista De Sarro, Emilio Russo, Antonio Gambardella & Angelo Labate. (2020) The efficacy of perampanel as adjunctive therapy in drug-resistant focal epilepsy in a “real world” context: focus on temporal lobe epilepsy. Journal of the Neurological Sciences 415, pages 116903.
Crossref
Crossref
Antonio Leo, Carmen De Caro, Valentina Nesci, Martina Tallarico, Giovambattista De Sarro, Emilio Russo & Rita Citraro. (2020) Modeling poststroke epilepsy and preclinical development of drugs for poststroke epilepsy. Epilepsy & Behavior 104, pages 106472.
Crossref
Crossref
Bernhard J. Steinhoff & Anke M. Staack. (2019) Is there a place for surgical treatment of nonpharmacoresistant epilepsy?. Epilepsy & Behavior 91, pages 4-8.
Crossref
Crossref
Serge Weis, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser & Peter StrasserSerge Weis, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser & Peter Strasser. 2019. Imaging Brain Diseases. Imaging Brain Diseases
1143
1156
.
Yam Nath Paudel, Mohd. Farooq Shaikh, Ayanabha Chakraborti, Yatinesh Kumari, Ángel Aledo-Serrano, Katina Aleksovska, Marina Koutsodontis Machado Alvim & Iekhsan Othman. (2018) HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction. Frontiers in Neuroscience 12.
Crossref
Crossref
Kuang-Lin Lin, Jainn-Jim Lin, Ming-Liang Chou, Po-Cheng Hung, Meng-Ying Hsieh, I-Jun Chou, Siew-Na Lim, Tony Wu & Huei-Shyong Wang. (2018) Efficacy and tolerability of perampanel in children and adolescents with pharmacoresistant epilepsy: The first real-world evaluation in Asian pediatric neurology clinics. Epilepsy & Behavior 85, pages 188-194.
Crossref
Crossref
Alessandra Morano, Jinane Fattouch, Mariarita Albini, Sara Casciato, Martina Fanella, Luca Manfredi Basili, Alessandro Viganò, Mario Manfredi, Anna Teresa Giallonardo & Carlo Di Bonaventura. (2018) Perampanel as adjunctive therapy in highly refractory epilepsies: Real-world data from an Italian tertiary care epilepsy centre. Journal of the Neurological Sciences 390, pages 67-74.
Crossref
Crossref
Antonio Leo, Giada Giovannini, Emilio Russo & Stefano Meletti. (2018) The role of AMPA receptors and their antagonists in status epilepticus. Epilepsia 59:6, pages 1098-1108.
Crossref
Crossref
Caihong Ji, Lujia Zhu, Cong Chen, Shuang Wang, Leilei Zheng & Hong Li. (2017) Volumetric Changes in Hippocampal Subregions and Memory Performance in Mesial Temporal Lobe Epilepsy with Hippocampal Sclerosis. Neuroscience Bulletin 34:2, pages 389-396.
Crossref
Crossref
Hirokazu Yamagishi, Hitoshi Osaka, Masako Nagashima, Mari Kuwajima, Akihiko Miyauchi, Takahiro Ikeda, Karin Kojima, Ayumi Matsumoto & Takanori Yamagata. (2018) Efficacy and Side Effect of Perampanel for Refractory Epilepsy. Journal of the Japan Epilepsy Society 35:3, pages 693-701.
Crossref
Crossref
Xiangchang Zeng, Siyu Chen, Qing Gao, Wenjing Zong, Dejian Jiang, Guirong Zeng, Luping Zhou, Lulu Chen, Wei Luo, Jian Xiao, Bo Xiao, Dongsheng Ouyang & Kai Hu. (2017) The expression of G protein-coupled receptor kinase 5 and its interaction with dendritic marker microtubule-associated protein-2 after status epilepticus. Epilepsy Research 138, pages 62-70.
Crossref
Crossref
Ganna Androsova, Roland Krause, Mojgansadat Borghei, Merel Wassenaar, Pauls Auce, Andreja Avbersek, Felicitas Becker, Bianca Berghuis, Ellen Campbell, Antonietta Coppola, Ben Francis, Stefan Wolking, Gianpiero L. Cavalleri, John Craig, Norman Delanty, Bobby P. C. Koeleman, Wolfram S. Kunz, Holger Lerche, Anthony G. Marson, Josemir W. Sander, Graeme J. Sills, Pasquale Striano, Federico Zara, Sanjay M. Sisodiya & Chantal Depondt. (2017) Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 58:10, pages 1734-1741.
Crossref
Crossref
Weihong Yang, Jing Li, Yun Shang, Li Zhao, Mingying Wang, Jipeng Shi & Shujun Li. (2017) HMGB1-TLR4 Axis Plays a Regulatory Role in the Pathogenesis of Mesial Temporal Lobe Epilepsy in Immature Rat Model and Children via the p38MAPK Signaling Pathway. Neurochemical Research 42:4, pages 1179-1190.
Crossref
Crossref
Giuseppe Borzì, Giancarlo Di Gennaro, Friedhelm C. Schmitt, Alfredo D'Aniello, Laura Mumoli, Lelila Zummo, Ornella Daniele, Emilio Russo, Antonio Gambardella & Angelo Labate. (2016) Lacosamide in patients with temporal lobe epilepsy: An observational multicentric open-label study. Epilepsy & Behavior 58, pages 111-114.
Crossref
Crossref
Rita Citraro, Antonio Leo, Andrew Constanti, Emilio Russo & Giovambattista De Sarro. (2016) mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis. Pharmacological Research 107, pages 333-343.
Crossref
Crossref
Lia Santulli, Antonietta Coppola, Simona Balestrini & Salvatore Striano. (2016) The challenges of treating epilepsy with 25 antiepileptic drugs. Pharmacological Research 107, pages 211-219.
Crossref
Crossref
Igor Kuzmanovski, Emilija Cvetkovska, Marija Babunovska, Gordana Kiteva Trencevska, Biljana Kuzmanovska, Bojan Boshkovski & Rozalinda Isjanovska. (2016) Seizure outcome following medical treatment of mesial temporal lobe epilepsy: Clinical phenotypes and prognostic factors. Clinical Neurology and Neurosurgery 144, pages 91-95.
Crossref
Crossref